REGISTERED
on 22 Oct 2019
Last Applicant/ Owned by
100 Binney Street, Suite 710
Cambridge
MA
02142
Serial Number
88174433 filed on 30th Oct 2018
Registration Number
5892910 registered on 22nd Oct 2019
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"TCR THERAPEUTICS"
TCR² THERAPEUTICS
The mark consists of four shaded oblongs centered above six shaded oblongs of the same size. The oblongs are to the left of the wording "TCR THERAPEUTICS" in stylized characters displayed on two lines with a "2" in stylized characters forming an exponent over "TCR". Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human Read More
Classification Information
Class [005]
Pharmaceutical Products
Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use in the nature of biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases
First Use Date in General
24th Jul 2019
First Use Date in Commerce
24th Jul 2019
Class [042]
Computer & Software Services & Scientific Services
Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
First Use Date in General
30th Nov 2016
First Use Date in Commerce
30th Nov 2016
Mark Details
Serial Number
No 88174433
Mark Type
No Service Mark
Attorney Docket Number
No 48538-TM1004
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.11.27 -
Oblongs not being used as carriers for words, letters or designs
Description of Design Search
The mark consists of four shaded oblongs centered above six shaded oblongs of the same size. The oblongs are to the left of the wording "TCR THERAPEUTICS" in stylized characters displayed on two lines with a "2" in stylized characters forming an exponent over "TCR".
Legal History
| Status Date | Action Taken |
|---|---|
| 22nd Oct 2019 | REGISTERED-PRINCIPAL REGISTER |
| 18th Sep 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 17th Sep 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 13th Sep 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Sep 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| 12th Sep 2019 | EXTENSION 1 GRANTED |
| 12th Sep 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 09th Sep 2019 | EXTENSION 1 FILED |
| 09th Sep 2019 | TEAS EXTENSION RECEIVED |
| 09th Sep 2019 | USE AMENDMENT FILED |